Zhang Zhi-Hong, Jiang Chuang, Li Jia-Xin
Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
World J Gastrointest Surg. 2024 Nov 27;16(11):3623-3628. doi: 10.4240/wjgs.v16.i11.3623.
In this letter, we comment on the article by Zhou that was published in the recent issue of the . This article proposes a new clinical grading system based on a multidisciplinary team, which prompts us to rethink the clinical management of hepatic hemangioma. Hepatic hemangioma is the most common benign solid liver tumor. In general, follow-up and observation for the vast majority of hepatic hemangioma is reasonable. For those patients with symptoms and severe complications, surgical intervention is necessary. Specific surgical indications, however, are still not clear. An effective grading system is helpful in further guiding the clinical management of hepatic hemangioma. In this article, we review the recent literature, summarize the surgical indications and treatment of hepatic hemangioma, and evaluate the potential of this new clinical grading system.
在这封信中,我们对周发表于最近一期[期刊名称未给出]上的文章发表评论。本文提出了一种基于多学科团队的新临床分级系统,这促使我们重新思考肝血管瘤的临床管理。肝血管瘤是最常见的肝脏良性实性肿瘤。一般来说,对绝大多数肝血管瘤进行随访观察是合理的。对于有症状和严重并发症的患者,手术干预是必要的。然而,具体的手术指征仍不明确。一个有效的分级系统有助于进一步指导肝血管瘤的临床管理。在本文中,我们回顾了近期文献,总结了肝血管瘤的手术指征和治疗方法,并评估了这种新临床分级系统的潜力。